Motor Neuron Disease and Risk of Cancer: A Population-Based Cohort Study in Denmark

References

• Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162–172. doi:10.1056/NEJMra160347128700839
   PubMed Web of Science ®Google Scholar
• Feigin VL, Abajobir AA, Abate KH, et al. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16(11):877–897. doi:10.1016/S1474-4422(17)30299-528931491
   PubMed Web of Science ®Google Scholar
• Driver JA. Inverse association between cancer and neurodegenerative disease: review of the epidemiologic and biological evidence. Biogerontology. 2014;15(6):547–557. doi:10.1007/s10522-014-9523-225113739
   PubMed Web of Science ®Google Scholar
• Ganguli M. A reduced risk of Alzheimer’s disease in those who survive cancer. BMJ. 2012;344:e1662. doi:10.1136/bmj.e166222411921
   PubMed Web of Science ®Google Scholar
• Catala-Lopez F, Suarez-Pinilla M, Suarez-Pinilla P, et al. Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies. Psychother Psychosom. 2014;83(2):89–105. doi:10.1159/00035649824458030
   PubMed Web of Science ®Google Scholar
• Ording AG, Veres K, Horvath-Puho E, et al. Alzheimer’s and Parkinson’s diseases and the risk of cancer: a cohort study. J Alzheimers Dis. 2019;72(4):1269–1277.31707368
   PubMed Web of Science ®Google Scholar
• Fang F, Al-Chalabi A, Ronnevi LO, et al. Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(5–6):362–368. doi:10.3109/21678421.2013.77530923527497
   PubMed Web of Science ®Google Scholar
• Gibson SB, Abbott D, Farnham JM, et al. Population-based risks for cancer in patients with ALS. Neurology. 2016;87(3):289–294. doi:10.1212/WNL.000000000000275727170569
   PubMed Web of Science ®Google Scholar
• Fois AF, Wotton CJ, Yeates D, Turner MR, Goldacre MJ. Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson’s disease: record linkage studies. J Neurol Neurosurg Psychiatry. 2010;81(2):215–221. doi:10.1136/jnnp.2009.17546319726405
   PubMed Web of Science ®Google Scholar
• Ording AG, Horvath-Puho E, Veres K, et al. Cancer and risk of Alzheimer’s disease: small association in a nationwide cohort study. Alzheimers Dement. 2020;16(7):953–964. doi:10.1002/alz.1209032432415
   PubMed Web of Science ®Google Scholar
• Akan O, Baysal-Kirac L. Amyotrophic lateral sclerosis with coexisting cancer: a single-center study. Acta Neurol Belg. 2020. doi:10.1007/s13760-020-01337-y
   Web of Science ®Google Scholar
• Verschueren A, Gallard J, Boucraut J, Honnorat J, Pouget J, Attarian S. Paraneoplastic subacute lower motor neuron syndrome associated with solid cancer. J Neurol Sci. 2015;358(1–2):413–416. doi:10.1016/j.jns.2015.08.01426323521
   PubMed Web of Science ®Google Scholar
• Mele N, Berzero G, Maisonobe T, et al. Motor neuron disease of paraneoplastic origin: a rare but treatable condition. J Neurol. 2018;265(7):1590–1599. doi:10.1007/s00415-018-8881-029725842
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SAJ, Adelborg K, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563–591. doi:10.2147/CLEP.S17908331372058
   PubMed Web of Science ®Google Scholar
• Schmidt M, Pedersen L, Sorensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-324965263
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S9112526604824
   PubMed Web of Science ®Google Scholar
• Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39(7Suppl):42–45. doi:10.1177/140349481039356221775350
   PubMed Web of Science ®Google Scholar
• Breslow NE, Day NE. Statistical methods in cancer research. Volume II–The design and analysis of cohort studies. IARC Sci Publ. 1987;82:1–406.
   Google Scholar
• Data Privacy Policy. Available from: https://www.dst.dk/ext/formid/datafortrolighed–pdf. Accessed 922, 2020.
   Google Scholar
• Freedman DM, Curtis RE, Daugherty SE, Goedert JJ, Kuncl RW, Tucker MA. The association between cancer and amyotrophic lateral sclerosis. Cancer Causes Control. 2013;24(1):55–60. doi:10.1007/s10552-012-0089-523090035
   PubMed Web of Science ®Google Scholar
• Turner MR, Goldacre R, Ramagopalan S, Talbot K, Goldacre MJ. Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology. 2013;81(14):1222–1225. doi:10.1212/WNL.0b013e3182a6cc1323946298
   PubMed Web of Science ®Google Scholar
• Hemminki K, Huang W, Sundquist J, Sundquist K, Ji J. Autoimmune diseases and hematological malignancies: exploring the underlying mechanisms from epidemiological evidence. Semin Cancer Biol. 2020;64:114–121. doi:10.1016/j.semcancer.2019.06.00531181268
   PubMed Web of Science ®Google Scholar
• Ansell P, Simpson J, Lightfoot T, et al. Non-Hodgkin lymphoma and autoimmunity: does gender matter? Int J Cancer. 2011;129(2):460–466. doi:10.1002/ijc.2568020853323
   PubMed Web of Science ®Google Scholar
• Sorensen HT, Riis AH, Lash TL, Pedersen L. Statin use and risk of amyotrophic lateral sclerosis and other motor neuron disorders. Circ Cardiovasc Qual Outcomes. 2010;3(4):413–417. doi:10.1161/CIRCOUTCOMES.110.93627820530788
   PubMed Web of Science ®Google Scholar
• Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011;377(9760):127–138. doi:10.1016/S0140-6736(10)62231-321183212
   PubMed Web of Science ®Google Scholar
• Wang M-D, Little J, Gomes J, Cashman NR, Krewski D. Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. Neurotoxicology. 2017;61:101–130. doi:10.1016/j.neuro.2016.06.01527377857
   PubMed Web of Science ®Google Scholar